TIAA Wealth Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124K Sell
576
-53
-8% -$10.1K ﹤0.01% 357
2026
Q1
$115K Buy
+629
New +$116K ﹤0.01% 327

Other funds holding BIIB

TIAA Wealth Investment Management's BIIB Position: Q2 2026 in Review

TIAA Wealth Investment Management reduced its Biogen (BIIB) stake by 8.4% in Q2 2026, selling an estimated $10.1K and leaving 576 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #357.

TIAA Wealth Investment Management first reported a position in BIIB in Q1 2026 and has held it in 2 quarters since. 981 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • TIAA Wealth Investment Management held 576 shares of Biogen worth $124K as of Q2 2026.
  • TIAA Wealth Investment Management sold 53 Biogen shares in Q2 2026, an estimated $10.1K.
  • Biogen made up ﹤0.01% of TIAA Wealth Investment Management's portfolio in Q2 2026, its #357 holding.
  • TIAA Wealth Investment Management first reported a position in Biogen in Q1 2026 and has held it in 2 quarters since.
  • 981 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on TIAA Wealth Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.